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Abstract
Background: The impact of bariatric surgery on abnormalities in blood lipids and lipoprotein metabolism during the perioperative 
period has been poorly studied.
Objective: We studied the impact of bariatric surgery on the composition and quantitative properties of lipoproteins and the activity 
of lipases in the plasma of perioperative morbidly obese patients.
Methods: We examined the plasma lipoproteins and lipolytic activities of 34 morbidly obese patients one month before surgery 
(OB), pre-anaesthesia (-S), post-anaesthesia (+S), and one day and one month after open Roux-en-Y gastric bypass (RYGB) surgery. 
Results: Surgical injury induced acute stress, as evidenced by transitory hyperglycaemia and elevated plasma levels of stress hor-
mones. Lipid profiles revealed a significant reduction during surgery and the day after in the plasma levels of total cholesterol (p < 
0.0001), which was mainly due to a decrease in low-density lipoprotein cholesterol (cLDL) and was confirmed with a significant 
reduction in the plasma levels of LDL (approximately 26% reduction). Significant (p < 0.0001) changes were detected in the plasma 
levels of high-density lipoprotein cholesterol (cHDL) as well as a significant decrease (approximately 19% reduction) in the plasma 
levels of HDL. A significant (p < 0.0001) rise was noted in the plasma levels of both Lipoprotein Lipase (LPL) (approximately 2.6-
fold increase) and hepatic lipase (HL) (approximately 2.2-fold increase) on the day after surgery, occurring simultaneously with the 
maximum increase in C-reactive protein (CRP) and a day after the peak values for non-esterified fatty acid (NEFA), adrenocorti-
cotropin hormone (ACTH), cortisol and glucose.
Conclusion: The present study reveals unreported quantitative perioperative changes in plasma lipases and lipoproteins and related 
metabolic determinants that may contribute to the adaptive metabolic response to RYGB-induced stress.
Summary: There was a significant rise in the plasma levels of plasma lipases on the day after surgery in morbidly obese patients, 
co-occurring with the maximum increase in C-reactive protein.
 Lipid profiles revealed a significant reduction during surgery and the day after in the plasma levels of cholesterol. 
Stress pre-/post-surgery caused important changes in NEFA, ketone bodies and other related parameters that could be used as mark-
ers of surgery risk.
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2Introduction
 Roux-en-Y gastric bypass (RYGB) is one of the most frequently employed surgical techniques used to sustain body weight 
reductions in morbidly obese patients. Most studies show impressive postoperative improvements in well-established cardio meta-
bolic risk factors, including the plasma levels of lipids and lipoproteins (Williams et al., 2007; Schernthaner et al., 2008; Ay et al., 
2010), in morbidly obese patients in the months following RYGB surgery. However, these factors have not been evaluated during 
and immediately following surgery. 
 Hyperglycaemia induced by surgical stress is a well-documented clinical phenomenon that is characterized by insulin 
resistance (Seematter et al., 2004) and has been at least in part attributed to the concomitant release of stress hormones during and 
after surgery. Supporting this concept, elevations in the plasma levels of stress hormones (i.e., adrenocorticotropin [ACTH] and 
cortisol) and glucose have been reported immediately after surgery (Nguyen et al., 2002a), with baseline levels recovering within 
24h thereafter.
 Aside from the adrenocortical response, a parallel adrenomedullary response occurs during different early phases of the 
bariatric perioperative period (Nguyen et al., 2002b). Inflammation is also induced by RYGB, as several systemic cytokines have 
been revealed as acute physiological stress markers in the perioperative phases of abdominal surgery (Maruna et al., 2008). In par-
ticular, plasma levels of CRP and IL-6/IL-8 are elevated during the early perioperative stages of RYGB (Nguyen et al., 2002 a,b; 
Schernthaner et al., 2008).
 Circulating levels of lipoproteins are influenced by inflammation and the acute phase response (Carpentier & Scruel, 2002; 
Jahangiri, 2010; Chung et al., 2011). However, the impact of surgery-induced stress on the plasma levels of both LDL and HDL 
during the perioperative period is controversial (Leszczynski et al., 1980; Carpentier & Scruel, 2002; Jahangiri, 2010). 
 Despite the long-term benefits of RYGB on lipid and lipoprotein metabolism in morbidly obese patients (Pardina et al., 
2009a; Julve et al., 2014), the direct analysis of its impact on lipids and lipoproteins during the early perioperative stages remains 
elusive. Given that surgery-induced biochemical abnormalities in the quantitative properties of lipoproteins worsen there atherogen-
ic and inflammatory properties (Carpentier & Scruel, 2002), lipoprotein levels in gastric bypass patients may be clinically relevant.
 This study examines the metabolic response to acute stress occurring during the perioperative phases of RYGB on the 
quantitative properties of plasma lipases and lipoproteins. Furthermore, this work will elucidate any identified association of lipases 
and lipoproteins with known and potentially novel acute perioperative phase markers.
Materials and Methods
Patient Selection
 A group of 34 subjects was recruited from morbidly obese patients (24 women and 10 men) between 20 and 60 years of age 
undergoing open RYGB surgery at the University Hospital, as described elsewhere (Pardina et al., 2009a; Julve et al., 2014). The 
diagnostic criteria used for comorbidities are detailed in the National Cholesterol Education Program (NCEP, 2001). All subjects 
were free of inflammatory and infectious diseases, and none were receiving anti-obesity or anti-inflammatory drugs at the time of 
the study. Patients were excluded if they had neoplastic, renal, or active systemic diseases; hypothyroidism; or an endocrine disease 
other than diabetes. All patients reported that their weight had been stable during the previous three months. None of the diabetic 
patients were being treated with insulin. The patients presented the necessary indications for bariatric surgery: BMI > 40 kg/m2 or 
greater than 35 kg/m2 with one or more comorbidities. Blood samples were drawn one month before surgery (OB), immediately 
before surgery (-S), immediately after surgery (+S), one day after surgery (1d), and 1 month after surgery (1M). The anaesthetic 
procedure was standardized for open RYGB. For induction, 2 mg•kg-1 ideal weight of propophol and fentanyl was administered. 
During surgery, anaesthesia was maintained with desflurane, 0.45mg•kg-1•h-1 of rocuronium bromide and 4 µg•kg-1•h-1 of fentanyl. 
Epinephrine was avoided. 
 For the control non-obese group of surgery (CS), we used blood samples obtained from 22 surgical non-obese patients (30 
– 80 years old) admitted to the same University Hospital. Patients were submitted to open surgery for colectomy (for colon carci-
noma) or gas trectomy (for gastric carcinoma). The anaesthetic procedure was as described above. Exclusion criteria were hepatic 
or renal failure, acute or chronic infection, diabetes mellitus or pregnancy. Blood samples were drawn 3 days before surgery (-3), 
immediately after surgery (0), and one day after surgery (1).
 For the non-stressed control (C) group, we used blood samples obtained from 21 students (18-25 years old) through a vol-
unteer donor blood bank.
 The study protocol was reviewed and accepted by the hospital ethics committee, and all subjects (patients and students) 
gave their written informed consent to participate.
 All blood samples were taken under fasting conditions at 8:00 and 10:00 am. Plasma was separated immediately by cen-
trifugation (2000xg, 30 min, 4ºC), and aliquots were frozen at -80°C for subsequent analysis.
Anthropometric and Body Composition Measurements
 Body weight, height, and waist and hip circumferences were measured according to standard procedures (Pardina et al., 
2009a). The body mass index (BMI) (kg/m2) was calculated for all subjects.
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Analytical methods
 Fasting plasma glucose, triglycerides, non-esterified fatty acids (NEFA), total cholesterol, and high- and low-density lipo-
protein cholesterol (cHDL and cLDL, respectively) were enzymatically measured using the hospital’s routine chemistry laboratory. 
Human apoA-I and apoB were quantified using commercially available turbidimetric assays (RAL). Human apoA-IV was deter-
mined by western blot assays as described elsewhere (Pardina et al., 2009b). Ketone bodies (KB) were indirectly determined by 
quantification of β-hydroxybutyrate via an enzymatic method (Kientsch-Engel et al., 1982).
Lipoprotein analysis
 Lipoprotein fractions were isolated by sequential micro-ultracentrifugation according to Rodríguez-Sureda et al. (2002). 
Lipoprotein subfraction composition was analysed for lipids, including total cholesterol, free cholesterol, phospholipids, and tri-
glycerides, and protein (total protein content) at the indicated times using commercial methods.
Determination of plasma levels of stress hormones and CRP
 ACTH, insulin and cortisol were measured in the IMMULITE 2500 auto analyser (Siemens Healthcare, Spain). The meth-
od for cortisol quantification was based on a competitive chemiluminescent enzyme immunoassay in solid phase. The insulin and 
ACTH assays were based on non-competitive chemiluminescent immunometric assays with two binding sites in the solid phase. 
 The homeostatic model assessment of insulin resistance (HOMA-IR) was calculated as previously described by Matthews 
et al. (1985). Plasma CRP was determined using a turbidimetric assay (Gernon, RAL; Spain).
LPL activity and mass assay
 LPL was assayed as previously described by Ballart et al. (2003). Endothelial lipase (EL) has no triglyceride hydrolase 
activity when 3 - 5% serum is present in the assay (McCoy et al., 2002). LPL mass was measured using an LPL ELISA kit (Sekisui 
Diagnostics).
HL activity assay
 HL activity was determined using the method described by Ehnholm & Kuusi (1986), with minor modifications. Both LPL 
and EL are inactive in this lipase assay due to the high NaCl concentration (Hultin et al., 1994). LPL is also inactive due to the lack 
of a serum cofactor.
Statistical analysis
 The results are presented as the mean ± SEM. Significant differences between the non-stressed control group (C) and the 
obese (OB) and the different time-points perioperative surgery (-S, +S, 1d, and 1M) on the plasma chemical parameters and on the 
composition and quantitative properties of lipoproteins were assessed using one-way ANOVA and Tukey’s multiple comparison 
post-tests. Significant differences between the non-stressed control group (C) and the obese (OB) at the different time-points periop-
erative surgery (-S, +S, 1d, and 1M) and non-obese control surgery (CS) at the different time-points perioperative surgery (-3, 0 
and 1) on the plasma chemical parameters were assessed using two-way ANOVA (anova-2) and Bonferroni multiple comparison 
post-tests. Correlations between the independent variables were determined by the multiple Spearman’s correlation coefficient (rho). 
Statistical comparisons were considered significant when p < 0.05. 
 All statistical analyses were computed using GraphPad Prism version 5.00 for Windows (GraphPad Software, San Diego 
California USA, www.graphpad.com).
Results
Perioperative impact of RYGB on clinical and biochemical characteristics of obese patients before and after bariatric sur-
gery
 As shown in Table 1, RYGB surgery produced a favourable decline in the body weight and BMI of morbidly obese patients 
1M after intervention. The plasma levels of glucose (Table 1 and Figure 1, panel A) increased significantly immediately after surgery 
(+S; approximately 1.4-fold vs. OB; P < 0.001, Table 1) in obese (OB) and non-obese stressed (CS) patients after surgery (0) vs. 
before surgery (-3) (approximately 1.3-fold; P < 0.01). Plasma glucose levels tend to recover to C values the day following surgery 
in OB and CS. Plasma insulin levels and insulin resistance (HOMA-IR) in OB significantly decreased (approximately 1.7-fold, P < 
0.05 and 2.3-fold, P < 0.01, respectively) 1M after surgery. 
Perioperative impact of RYGB on the plasma levels of stress hormones and CRP
 Plasma levels of glucose are a marker of acute stress and are positively related to stressor intensity and could be used to 
evaluate it (Armario et al., 1990). As we commented before, the surgery was associated with an increase in that parameter in both 
OB and CS (Table 1 and Figure 1, panel A). The plasma levels of cortisol reached a peak (approximately 2.3-fold vs. OB; P < 0.001 
and 1.6-fold vs. -3; P < 0.001) during the same post-surgical phase (+S or 0, respectively) (Figure 1, panel B). That peak was coin-
cident with the peak of glucose but also with the ACTH peak (10-fold; P < 0.001) immediately after surgery (+S) compared with the 
OB values and dropped until reaching baseline values 1d after surgery (data not shown). The levels of both hormones were directly 
correlated (rho = 0.703, P < 0.001; Table 3). Remarkably, the plasma levels of cortisol were different (P < 0.05) between OB and CS, 
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4but in both cases were directly correlated (Table 3) with the plasma levels of glucose (OB: rho = 0.376, P < 0.001; CS: rho = 0.301, 
P < 0.05). That correlation did not exist in the C group.
 The plasma levels of CRP were significantly elevated 1d after surgery in the OB group (approximately 3.8-fold, P < 0.001), 
but in the CS group, the increase was 13.5-fold (P < 0.001) (Figure 1, panel C).The values between these two groups are very dif-
ferent (P < 0.001). The enzyme LPL in the CS group was correlated with CRP (rho = 0.401, P < 0.01), but there was no correlation 
in the C group. Levels of CRP were also negatively correlated (Table 3) with the plasma levels of cortisol, despite the low r value 
(in the OB group: rho = -0.183, P < 0.05; and in the CS group: rho = -0.383, P < 0.01; there was no correlation in the C group) but 
also with ACTH (rho = -0.409, P < 0.001), glycerol (rho = -0.412, P < 0.001) and NEFA (rho = -0.321, P < 0.001) in the OB group 
(Table 3). We are aware that the correlations are low and that their predictive capacity is therefore minimal. However, we preferred 
not to eliminate the extreme values because they correspond to patients who might be at greater risk than the rest of the patients who 
are part of the majority group (see Supplementary “Figures 1 and 2”).
Table 1: Clinical and biochemical characteristics of obese patients before and after bariatric surgery.
Parameters C OB -S +S 1 d 1 M P (ANOVA)
Anthropometrics
Weight (Kg) 130.3 ± 3.4 nd nd nd 115.2 ± 3.2 < 0.0001
BMI (Kg/m2) 48.8 ± 0.9 nd nd nd 42.3 ± 1.6 < 0.0001
Glucose metabolism
Insulin (mU/L) 24.3 ± 2.8 20.0 ± 2.9 x 22.2 ± 2.3 31.3 ± 3.1 *** 13.9 ± 1.6 o 0.0002
Glucose (mg/
dL) 100.0 ± 4.0 126.3 ± 9.6 nd 178.2±12.0 ººº
,***,ccc,x 143.0  ± 7.7 ** 96.2 ± 3.4 < 0.0001
HOMA-IR nd 7.7 ± 1.1 nd 9.2  ±  2.2 10.4 ± 1.7 ** 3.3  ±  0.5 ºº 0.0006
Lipidmetabolism
Total cholester-
ol (mg/dL) 164.3 ± 2.9 212.9 ± 7.2
 ccc 224.1±12.5 ***,ccc 202.2 ± 10.7 * 175.4 ± 15.1 ooo 154.2 ± 7.6ooo < 0.0001
FC (mg/dL) 39.2 ± 1.3 47.1 ± 6.0 44.2 ± 5.1 40.3 ± 4.5 38.4 ± 6.0 40.2 ± 5.0 ns
EC (mg/dL) 125.1 ± 2.8 174.2 ±15.6 ccc 180.0 ± 11.4 ccc 160.0 ± 13.8 137.1 ± 14.6 143.4 ± 9.8 < 0.0001
cLDL(mg/dL) 116.3 ± 5.3 136.5 ± 5.4 120.6 ± 13.2 103.5 ± 11.0 o 85.5 ± 10.4 ooo 91.3 ± 6.8 ooo < 0.0001
cHDL(mg/dL) 50.2 ± 2.2 48.3 ± 1.6 35.7 ± 2.9 oo,cc 40.7 ± 3.8 38.3 ± 3.5 o,c 33.5 ± 1.2 ooo,ccc < 0.0001
Triglycerides 
(mg/dL) 57.8 ± 2.1 140.3 ± 8.8
 ccc 174.7 ± 36.1 ccc 130.4 ± 27.7 ccc 123.5 ± 20.3 ccc 147.1 ± 10.6 ccc < 0.0001
Phospholipids 
(mg/dL) 155.2 ± 3.6 195.3 ± 2.8
 ccc 189.0 ± 3.3 ccc 180.2 ± 4.0 c 164.2 ± 4.4 o 166.0 ± 5.0 < 0.0001
ApoA-I (mg/
dL) 197.5 ± 6.4 185.6 ± 5.0
165.1 ± 5.0 o,xxx-
,***,ccc 145.5±4.6
ooo, s,*,ccc 133.1 ± 3.7ooo, ccc 126.4 ± 3.6 ooo,ccc < 0.0001
ApoA-IV (a.u.) 110 ± 11 100.0 ± 0.0 85.8 ± 5.6 ** 82.7±7.7 * 73.0 ± 5.9 o,cc 56.8 ± 5.0 ooo,ccc < 0.0001
ApoB (mg/dL) 68.4 ± 4.9 85.1 ± 3.0 c 79.4± 3.4o, xxx,*** 72.5 ± 3.0 x 59.8 ± 2.8 ooo 70.5 ± 3.4 o < 0.0001
Glycerol (μM) 59.1 ± 11.7 199.7 ± 9.5 ccc 220.6±15.2xxx,ccc 238.6±14.1xxx,ccc 1 2 8 . 1 ± 1 0 . 3 ooo,*** 218.6 ± 12.4
 ccc < 0.0001
NEFA (mM) 0.29 ± 0.01 0.60 ± 0.04 ccc 0.72 ± 0.05 x,**,cc 1.00±0.05 ooo, ss,xxx,ccc 0.54± 0.03 ccc,*** 0.95 ± 0.07 ooo,ccc < 0.0001
KB (μM) 84.6 ± 26.3 75.9 ± 13.7 80.0 ± 9.6 *** 229.7±36.7 *** 90.6 ± 17.8 *** 953.8 ± 148 ooo,ccc < 0.0001
The data are expressed as the mean ± SEM. Statistics were computedusing one-way ANOVA and Tukey’s multiple comparison post-tests. Abbrevi-
ations: BMI, body mass index; HOMA-IR, homoeostasis model assessment-insulin resistant; FC, free cholesterol; EC, esterified cholesterol; apo, 
apolipoprotein; NEFA, non-esterified fatty acid; KB, ketone bodies; OB, obese; -S, before surgery; +S, after surgery; 1d, one day after surgery; and 
1M, one month after surgery; nd, not determined. Symbols denote the differences between groups: (c) vs C; (º) vs OB; (s) vs –S; (x) vs 1d; (*) vs 
1M. One symbol, p < 0.05; two symbols, p < 0.01; three symbols, p < 0.001; ns, non-significant.
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Table 2: Relative chemical composition of plasma lipoproteins of obese patients before and after bariatric surgery.
C OB -S +S 1 d 1 M P (ANOVA)
VLDL
Free cholesterol (%) 3.2 ± 0.5 3.6 ± 0.3 4.1 ± 0.3 3.6 ± 0.4 3.5 ± 0.2 3.9 ± 0.3 ns
Esterified cholesterol (%) 6.6 ± 1.0 4.2 ± 0.5 4.2 ± 0.4 4.0 ± 0.6* 4.2 ± 0.6 3.8 ± 0.3 0.0281
Triglycerides (%) 80.4 ± 1.4 61.0 ± 2.3ccc 58.3 ± 1.7ccc 61.6 ± 3.0ccc 62.4 ± 2.1ccc 60.4 ± 2.4ccc < 0.0001
Phospholipids (%) 7.9 ± 0.8 25.0 ± 2.0ccc 25.8 ± 1.5ccc 24.2 ± 2.3ccc 26.0 ± 1.7ccc 25.0 ± 2.2ccc < 0.0001
Protein (%) 1.9 ± 0.8 6.2 ± 0.7 7.5 ± 0.7c 6.6 ± 0.8c 7.4 ± 0.8c 6.9 ± 0.8c 0.0161
Ratio lipid/protein (a.u.) 22.3 ± 3.2 18.7 ± 2.0 15.0 ± 1.6 21.5 ± 4.7 16.1 ± 2.3 17.5 ± 2.3 ns
Ratio n/s (a.u.) 7.6 ± 0.4 2.15 ± 0.28ccc 1.74 ± 0.10ccc 2.00 ± 0.19ccc 2.22 ± 0.24ccc 2.09 ± 0.27ccc < 0.0001
VLDL mass (% vs OB) 73.0 ± 13.0 100 ± 0 137 ± 15c 153 ± 36c 102 ± 14 100 ± 16 ns
LDL
Free cholesterol (%) 13.9 ± 1.0 7.5±  0.3ccc 7.5 ± 0.4ccc 6.9 ± 0.4ccc 7.1 ± 0.4ccc 7.3 ± 0.4ccc < 0.0001
Esterified cholesterol (%) 32.0 ± 1.9 19.4 ± 0.8ccc 19.8 ± 0.9 ccc,* 19.05 ± 0.6ccc 18.2 ± 0.7ccc 16.6 ± 0.6ccc < 0.0001
Triglycerides (%) 12.3 ± 0.8 20.3 ± 1.2 22.0 ± 1.4c 22.6 ± 1.8cc 23.8 ± 1.6cc 25.0 ± 1.6ccc 0.0005
Phospholipids (%) 27.1 ± 1.8 34.2 ± 1.8 33.0 ± 1.8 33.0 ± 1.7 34.3 ± 1.8 33.1 ± 1.7 ns
Protein (%) 14.8 ± 1.2 18.7 ± 1.3 17.4 ± 1.1 18.0 ± 1.4 16.6 ± 1.1 18.0 ± 1.4 ns
Ratio lipid/protein (a.u.) 3.0 ± 0.5 5.0 ± 0.4 5.1 ± 0.3 5.2 ± 0.4 5.5 ± 0.4 5.3 ± 0.5 ns
Ratio n/s (a.u.) 0.77 ± 0.07 0.67 ± 0.03 0.74 ± 0.04 0.75 ± 0.05 0.74 ± 0.04 0.73 ± 0.04 ns
LDL mass (% vs OB) 219 ± 23 100 ± 0*** 162 ± 14 ºº,ccc 148 ± 11cc 125 ± 12ccc 140 ± 13ccc < 0.0001
HDL
Free cholesterol (%) 4.3 ± 1.1 2.3 ± 0.1ccc 2.0 ± 0.1ccc 2.5 ± 0.1ccc 2.5 ± 0.1ccc 2.2 ± 0.2ccc < 0.0001
Esterified cholesterol (%) 16.5 ± 2.4 7.2 ±  0.7ccc 6.4 ± 0.5ccc 7.8 ± 0.4ccc 7.7 ± 0.4ccc 7.5 ± 0.5ccc < 0.0001
Triglycerides (%) 3.9 ± 0.5 5.2 ± 0.3 5.9 ± 0.4 6.9 ± 0.5º,cc 6.4 ± 0.5c 5.9 ± 0.5 0.0094
Phospholipids (%) 22.1 ± 1.8 24.6 ± 2.2 24.0 ± 2.1 29.9 ± 1.8 28.5 ± 2.1 26.1 ± 1.9 ns
Protein (%) 53.1 ± 4.6 60.7 ± 3.0 61.6 ± 2.7 53.0 ± 2.1 54.9 ± 2.4 58.3 ± 2.7 ns
Ratio lipid/protein (a.u.) 1.2 ± 0.1 0.7 ± 0.1 0.7 ± 0.1 1.0 ± 0.1 0.9 ± 0.1 0.8 ± 0.1 0.0107
Ratio n/s (a.u.) 0.22 ± 0.04 0.14 ± 0.01cc 0.14 ± 0.01cc 0.17 ± 0.01 0.16 ± 0.01c 0.16 ± 0.01c 0.0060
HDL mass (% vs OB) 104 ± 7 100 ± 0 89 ± 3 81 ± 5 78 ± 5 º,c 79 ± 4 0.0014
Lipoproteins were isolated by micro-ultracentrifugation from the fasting plasma of obese subjects before and after bariatric surgery at the indicated 
perioperative phases. The effect of surgery on the relative chemical composition of plasma lipoproteins was determined by comparing the OB 
values with those obtained at the indicated times after surgery. The data are expressed as the mean ± SEM. Statistics were computedusing one-
way ANOVA and Tukey’s multiple comparison post-tests. Abbreviations: HDL, high-density lipoproteins; LDL, low-density lipoproteins; VLDL, 
very-low-density lipoproteins; ratio n/s, ratio nucleus/surface; OB, obese; -S, before surgery; +S, after surgery; 1 d, one day after surgery; and 1 
M, one month after surgery. Symbols denote significant differences between groups: (c) vs C; (º) vs OB; (*) vs 1M. One symbol, p < 0.05; two 
symbols, p < 0.01; three symbols, p < 0.001; ns, non-significant. In the non-obese stressed (CS) group these parameters were not determined by 
lack of sample.
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Figure 1: Perioperative changes in stress and inflammatory makers in 
morbidly obese patients undergoing RYGB.
TABLE 3: Correlation between different plasma parameters in obese patients during before and after bariatric surgery.
Parameter Cortisol CRP Glucose Glicerol  KB  ACTH 
LPL -0.211** 0.190* -0.255** -0.331***
HL -0.168* 0.196* -0.212* -0.258*** -0.277***
CRP -0.183*
Glucose  0.376*** 
Glicerol -0.412*** 0.215*
KB  0.333***  0.380***  0.300*** 
ACTH  0.703*** -0.409***  0.311*** 0.242**
NEFA  0.326*** -0.321***  0.364***  0.530***  0.659***  0.286*** 
LPL = lipoprotein lipase; HL = hepatic lipase; CRP = C-reactive protein; KB = ketone bodies; ACTH =adrenocorticotropinhormoneand NEFA = 
non-esterified fatty acids. Correlations were determined by the Multiple Spearman’s correlation coefficient. (*) One symbol, p < 0.05; two sym-
bols, p < 0.01; ns, non-significant. It is noteworthy that none of these correlations were observed in the control (C) group. The values shaded in 
gray are at the limit (0 - 0.25) of what is considered little or no regression, but indicates a trend.In the non-obese stressed (CS) group there was a 
negative correlation between cortisol and CRP (r = -0.383, P < 0.01) and positive with glucose (r = 0.301, P < 0.05), the rest of parameters were 
not determined by lack of sample.
Figure 2: Perioperative changes on cLDL and cHDL in morbidly obese 
patients undergoing RYGB.
Perioperative Changes in Plasma Lipids
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Figure 3: Total circulating mass of VLDL, LDL and HDL lipoproteins 
in morbidly obese patients undergoing RYGB.
Figure 4: Perioperative changes in plasma lipolytic enzymes in mor-
bidly obese patients undergoing RYGB.
Perioperative impact of RYGB on lipids and lipoproteins 
 We observed a small but significant (P < 0.0001) in-
crease in total cholesterol, EC and TAG (Table 1) immediately 
before surgery (-S), but after surgery (+S) and 1d after surgery, 
the values tended to decline to recover after 1M of surgery, 
except for total cholesterol. Concomitant with the cholesterol 
decrease, we observed a significant (P < 0.0001) decline in the 
plasma levels of cLDL (Table 1 and Figure 2, panel A) and its 
corresponding cholesterol content (P < 0.0001, Table 2). Sup-
porting this finding, the plasma levels of apoB (approximate 
decrease of 1.4-fold vs. OB; P < 0.001, Table 1), which is the 
main protein constituent of VLDL and LDL, and plasma levels 
of LDL (p < 0.0457) were diminished slightly during the same 
perioperative period (Tables 1 and 2; and Figure 3, panel B).The 
cholesterol content also declined significantly (P < 0.0001, Ta-
ble 2). It should be noted that the cLDL profile of the CS group 
(Figure 2, panel A) is similar to that of the OB group, except that 
in the CS group, both before (-3) and surgery (0) are superior 
(1.4-fold) and in the first case are very significantly (P < 0.001) 
different.
 The decrease in the plasma levels of HDL mass (Fig-
ure 3, panel C) vs. OB before and after surgery (11 and 19%, 
respectively) was identified from the lipid profile (Table 2). At 
the same time, a significant decrease (P < 0.0001) in the plasma 
levels of apoA-I (approximate decrease of 23%; P < 0.05 and 
13%; p < 0.001, respectively, Table 1), which is the main protein 
constituent of HDL, was observed. A parallel decrease (27%) in 
the plasma levels of apoA-IV was also observed, although statis-
tical significance was reached from 1M (43%) onward after in-
tervention (Table 1). Of note, the reduction in plasma HDL (Fig-
ure 3, panel C) was maximal at 1d post-surgery (approximately 
22% below OB, P < 0.001) and occurred in conjunction with 
a smallincrease in the relative content of cholesteryl esters and 
triglycerides contained within the lipoproteins (Table 2). The 
group of non-obese subjects (CS) had 1.5 times less cHDL (Fig-
ure 2, panel B) than the obese patients (OB), and the decrease 
that occurred with surgery was very significant (P < 0.001) and 
much more marked (63% in CS and 26% in OB).
 The plasma levels of triglycerides in OB reached a peak 
(approximately 1.2-fold vs. OB, Table 1). That peak was coin-
cident with the plasma level peak of VLDL, which is the main 
carrier of triglycerides under fasting conditions during the early 
phase of surgery (Table 2 and Figure 3, panel A). Significant 
changes in their biochemical composition or size were observed, 
as predicted by their calculated n/s ratio (Table 2). 
 Remarkably, the increase in the plasma level of VLDL 
was also found to be partially associated with a rise in the plas-
ma NEFA level (Table 1), which reached maximum significance 
at the post-surgery (+S) time-point (approximately 1.7-fold in-
crease; P < 0.001). At pre-surgery time-points, plasma levels of 
NEFA displayed a trend towards being elevated (approximately 
1.4-fold higher). Plasma levels of glycerol paralleled those of 
NEFA (rho = 0.530, P < 0.001) (Table 3). The transitory increase 
in the plasma glycerol levels (Table 1) during the perioperative 
period reached statistical significance and was directly correlat-
ed (Table 3) with the plasma levels of ACTH (rho = 0.242, P < 
0.01). Additionally, the perioperative pattern of plasma levels of 
ketone bodies was similar to plasma NEFA levels (rho = 0.608, 
P < 0.001) (Table 3). 
Perioperative impact of RYGB on the plasma levels of lipo-
lytic enzymes
 The change in the plasma activities of lipolytic en-
zymes (LPL and HL) in response to surgery is shown in Figure 
4. Both plasma LPL (panel A) and HL (panel B) activities in OB 
showed a significant peak at 1d after surgery (LPL: 2.6-fold, P < 
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0.001; HL: 2.2-fold, P < 0.001). That increase was also observed 
in CS (LPL: 3.5-fold, P < 0.01; HL: 2.9-fold, P = ns). The differ-
ence between OB and CS was also highly significant (LPL: 2.4-
fold, 1d vs. 1; P < 0.001 and HL: 8.2-fold 1d vs. 1; P < 0.001). 
In contrast, the plasma LPL mass (data not shown) determined 
1d after surgery (40.6 ± 3.1 ng/mL) did not significantly differ 
from that determined at baseline (44.3 ± 3.3 ng/mL). The peak 
of plasma LPL activity observed at 1d after surgery coincided 
with a reduction in the mass/activity ratio of this enzyme, which 
was approximately 96% lower (P < 0.01) than that calculated 
at baseline (data not shown). The peak LPL and HL activities 
were coincident with the time of the CRP peak, just after the cor-
tisol, glucose and ACTH peaked in OB patients. Interestingly, 
the activities of both plasma lipolytic enzymes were positively 
correlated only in the OB group (rho = 0.586, P < 0.001) but 
also with the levels of ACTH, CRP and cortisol (Table 3). We 
also observed a negative correlation between LPL and HL with 
different parameters of cholesterol content: LPL with cLDL (rho 
= -0.312, P < 0.001) and with cHDL (rho = -0.281, P < 0.01). In 
the case of HL, the correlation was with con cLDL (rho = -0.367, 
P < 0.001) and with cHDL (rho = -0.322, P < 0.001).
Discussion
 The study presented here was performed between 2003 
and 2007, when laparoscopy surgery was not a standard tech-
nique at our hospital. The study focused only on the obese group 
(OB) and the changes that occurred in the lipase and lipid pa-
rameters before, during and after surgery. The non-obese group 
(CS) was used only as a surgical stress control, and a detailed 
study of lipoproteins was not undertaken in that group. Although 
at present most surgery in the morbidly obese is carried out by 
laparoscopy or is robotized, in some cases, due to complications, 
one must resort to open surgery (Schwartz et al., 2004). 
 On the other hand, in recent years articles have ap-
peared in which both procedures (Nguyen et al., 2000; Nguy-
en et al., 2002a,b; Zengin et al., 2002) are compared in terms 
of stress parameters as well as cytokines and other biochemical 
parameters. After laparoscopic and open RYGB, plasma concen-
trations of insulin, glucose, epinephrine, dopamine, and cortisol 
increased, but there was no significant difference in these param-
eters between groups (Nguyen et al., 2002a). The concentrations 
of norepinephrine, ACTH, C-reactive protein, and IL-6 also 
increased, but these levels were significantly (p < 0.05) lower 
after laparoscopic RYGB than after open RYGB (Nguyen et al., 
2002a). 
 Major surgery is frequently characterized by a string of 
metabolic, acute phase, and inflammatory responses (Nguyen et 
al., 2002a; Black, 2003). Acute stress, which is known to occur 
during the early perioperative phases (first 6 h) of surgery, is 
frequently characterized by a state of insulin resistance (Schern-
thaner & Morton, 2008). In our patients, insulin resistance was 
evidenced by a transient elevation in the plasma levels of glu-
cose and HOMA-IR and an enhanced adrenocortical response 
promoted by high plasma levels of stress hormones (Lin et al., 
2000; Schernthaner& Morton, 2008). Supporting previous data 
(Nguyen et al., 2002a), in this study, the plasma levels of both 
ACTH and cortisol peaked during the post-anaesthesia phase 
and declined the day after surgery. This time-course concurred 
with the most stressful segment of the intervention, which is 
the extubation of the patient (Udelsman & Holbrook, 1994). As 
previously reported (Clearfield, 2005), a significant rise in the 
levels of CRP, which is frequently associated with the extent of 
perioperative injury, was observed immediately after the inter-
vention (1d). Simultaneously, the two lipolytic enzymes (LPL 
and HL) in plasma increased, which has not been described pre-
viously. It is noteworthy that the release of these enzymes by 
the extra hepatic tissues (adipose, muscle) in the case of LPL 
or the liver in the case of HL is not due to the action of heparin 
administered during the surgery, but rather a change due to the 
hormonal action or the regulation of the enzyme itself.
 Despite the long-term benefits of bariatric surgery on 
lipoprotein metabolism (Carpentier & Scruel, 2002; Maruna et 
al., 2008; Chung et al., 2011), the perioperative time-course of 
plasma levels of lipids, lipoproteins and metabolic determinants 
has not been extensively studied. The present work is therefore 
one of the few studies that has focused on directly dissecting the 
course of quantitative changes in the main plasma lipoproteins 
and lipolytic enzymes (LPL and HL) occurring during the imme-
diate perioperative phases of RYGB.
 Circulating VLDL was slightly elevated during the 
pre- and post-anaesthesia stages. Perhaps this small increase 
could not induce the concomitant elevation in the composition 
(TAG) of these lipoproteins, despite increasing plasma levels of 
triglycerides. During this perioperative period, a commensurate 
increase in plasma NEFA roughly paralleled that of VLDL lev-
els in our study. Therefore, the elevation in the plasma levels of 
VLDL may be attributed to a stimulation of hepatic VLDL pro-
duction and secretion. This secretion may result from increased 
disposal of NEFA by this organ in our postoperative obese pa-
tients rather than by decreased lipolysis of these lipoproteins in 
the plasma (Holm, 2003). Supporting this concept, both insulin 
resistance (Holm, 2003) and elevated plasma levels of stress 
hormones (Peckett et al., 2011) promote lipolysis in adipose tis-
sue and lead to enhanced release of NEFA into the plasma and 
its accumulation in triglycerides in the liver. Moreover, because 
NEFA are synthesized into ketone bodies in the liver (Goldstein 
& Elwyn, 1989) the increase in the plasma levels of ketone bod-
ies that occurred in conjunction with the rise in NEFA levels 
may be further evidence of an increased intake of NEFA by the 
liver during these perioperative stages. Considering that elevat-
ed levels of cortisol also promote the hepatic secretion of apoB 
(Brindley et al., 1993), the rise in this stress hormone may pro-
mote the formation and release of triglycerides in the form of 
VLDL in our patients.
 The subsequent decline in the plasma levels of VLDL 
was further associated with an elevation in the plasma levels of 
LPL, a known determinant of the circulating levels of these lipo-
proteins (Olivecrona & Olivecrona, 2010). Enhanced release of 
LPL by adipose fat depots in response to inflammation has been 
described in previous reports in humans (Kientsch-Engel et al., 
1982) and experimental animals (Ricart-Jane, et al. 1985). 
 We have observed the same response to surgical stress 
in obese and non-obese humans. In both groups, the peak LPL 
activity (2.6 times higher in the obese) and HL (8.2 times higher 
in the obese) appeared in plasma, concomitant with increased 
CRP in plasma (2 times higher in non-obese) one day after sur-
gery, which is preceded by peaks or increments (of similar mag-
nitude in both groups) in glucose, NEFA, cortisol and ACTH 
(this latter only in the OB group) immediately after surgery and 
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coinciding with extubation.
 In a previous study (Sabugal, et al., 1996), we observed 
that surgery stress after partial hepatectomy in rats produced a 
peak in LPL activity 6h after surgery. In addition, after acute 
and/or chronic stress produced by body immobilization, a nota-
ble response in both lipid (increase in plasma NEFA and glyc-
erol) and lipoprotein (decrease in plasma TAG and increase in 
total cholesterol) was observed. These changes suggest that cat-
echolamines and glucocorticoids, which are segregated and syn-
thesized under such conditions, may alter LPL activity directly 
or indirectly in various tissues (Ricart-Jané, et al. 2002).
 Treatment of guinea pigs with an ACTH analogue in-
duced a 12-fold increase in serum cortisol and in LPL mRNA 
(about two-fold) and LPL activity (Gafvels et al., 1991). ACTH 
decreases hepatic lipase activity and low-density lipoprotein 
concentrations in healthy men (Berg et al., 1991); however, in 
our obese patients, although we observed a significant decrease 
in LDL and 1.6 times less cLDL 1 d after surgery, the HL in-
creased 2.2-fold. Some authors (Akgun et al., 1998; Kaw & 
Singh, 2001) have proposed both CRP and IL6 but not lipase 
as markers of the severity of pancreatitis. We propose that both 
LPL and HL, such as the typical acute stress markers glucose, 
ACTH, cortisol and CRP, may serve as indicators of the changes 
that occur with surgical stress in morbid obesity. Our finding 
may be the first suggesting these enzymes as potential plasma 
markers of the acute phase response.
 Although the impact of surgery-induced stress on the 
plasma levels of both LDL and HDL during the perioperative 
interval is controversial (Nguyen et al., 2002b; Leszczynski et 
al., 1980; Carpentier & Scruel, 2002; Jahangiri, 2010), it is gen-
erally accepted that their plasma levels and properties are influ-
enced by inflammation and the acute phase response (Carpen-
tier&Scruel, 2002; Jahangiri, 2010). Consistent with previous 
studies (Udelsman & Holbrook, 1994; Akgun et al., 1998) and 
other types of acute phase reactions, including sepsis (Carpenti-
er & Scruel, 2002; Fitrolaki et al., 2013), the plasma concentra-
tion of cholesterol generally parallels a significant reduction in 
the plasma levels of these lipoproteins.
 Although we did not determine the underlying causes 
of the effect of surgery on the reduction in the circulating levels 
of these lipoproteins in our postoperative patients, it is reason-
able to consider that their metabolism (i.e., the rate they are se-
creted or cleared) may be somewhat compromised by surgical 
procedure-related injury. In this regard, the elevation observed 
in the plasma levels of VLDL immediately before and after in-
tervention may suggest that the production of LDL would be 
barely augmented at best. Therefore, the observed reduction in 
the plasma levels of cLDL may result from increased particle 
clearance via its main receptor, the LDL receptor. Supporting 
this idea, the expression of this receptor in hepatic cells is in-
duced by inflammatory cytokines (Gierens et al., 2000).
 The perioperative RYGB-induced reduction in plas-
ma levels of HDL has been reported extensively (Chimienti et 
al., 2006 Morinigo et al., 2007). Other authors observed that 
serum cholesterol and its LDL and HDL fractions are reduced 
after major surgery, with a significant inverse correlation with 
peak serum IL-6 levels at 24 hours after surgery (Akgun et al., 
1998). The plasma levels of cLDL and cHDL shown in the lipid 
profile reveal a small but significant decrease. At the same time, 
our data revealed the presence of predominantly larger lipid-rich 
particles immediately after surgery (see ratio lipid/protein and 
n/s in Table 2). Similar to lipoprotein lipase, hepatic lipase was 
found to increase with CRP. Our data may be the first to reveal 
an increase in those lipases in the plasma, paralleling that of an 
acute phase protein that may contribute to the changes in both 
the composition and the plasma levels of VLDL, LDL and HDL 
during these perioperative stages. 
 It is noteworthy that in the perioperative phases of our 
study, NEFAs are highly sensitive and correlated with the chang-
es that occur in lipases and lipoproteins. It would be interesting 
to explore this aspect in future research. 
 We would also like to point out that those patients who 
show a series of parameters related to stress, such as ACTH, 
cortisol or glucose, who show extreme values during or imme-
diately after surgery, should be given special care, as it is highly 
probable that the rest of the metabolic parameters, such as lipids, 
lipases, and CRP, are also altered and could represent a postop-
erative risk factor.
 One of the limitations of our study was the failure to 
carry out a study of the lipoprotein composition in the non-obese 
patients, although this does not invalidate the results obtained.
 In conclusion, our data revealed novel perioperative 
systemic parameters related to lipid and lipoprotein metabolism 
in different phases of RYGB intervention. In this regard, sur-
gery was associated with unreported changes in some quantita-
tive characteristics of lipases and lipoproteins during the early 
phases of the intervention. Furthermore, an unreported direct 
association between the plasma levels of CRP and two main 
plasma lipolytic enzymes was also identified, thereby suggest-
ing a potential role for these lipases as emerging predictors of 
the acute phase response.
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supplementary Figures 1 and 2
Supplementary Figure 1: Correlation and linear regression between 
plasma LPL activity and different parameters.
Supplementary Figure 2: Correlation and linear regression between 
plasma HL activity and different parameters.
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